OasisLMS

Recent Advances in Gonadotropin Signaling and Therapy - Chair
Presenter: George Bousfield, PhD (Wichita State University)
Relationship: Commercial Interest(s)
  Grant Recipient: GlycoFormA Ltd.
  Owner/Co-Owner: GlycoFormA Ltd.

Recent Advances in Gonadotropin Signaling and Therapy - Novel Insights into FSH Regulation by Inhibins and Activins
Presenter: Daniel Bernard, PhD (McGill University)
Relationship: Commercial Interest(s)
  Consulting Fee: Akcea Therapeutics, Regeneron Pharmaceuticals.
  Akcea Therapeutics, Amgen Inc, Ionis Pharmaceuticals Inc., Novartis Pharmaceuticals, Pfizer, Inc., Regeneron Pharmaceuticals, Sanofi-Aventis.: Other

Recent Advances in Gonadotropin Signaling and Therapy - The Luteinizing Hormone Receptor Knockout Mouse as a Tool to Probe the In Vivo Actions of Gonadotropic Hormones/Receptors in Females
Presenter: Kim Jonas, PhD, BSc, PGCert (King's College London)
Relationship: Commercial Interest(s)
  Grant Recipient: GlycoFormA Ltd.
  Owner/Co-Owner: GlycoFormA Ltd.

Recent Advances in Gonadotropin Signaling and Therapy - Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival
Presenter: Livio Casarini, PhD (University of Modena and Reggio Emilia)
No relevant financial relationships